LRG Internal Research

The Life Raft Group maintains a comprehensive database to track medical trends in GIST treatment. We recently published a long-term study that examined GIST patients’ overall survival since starting Gleevec. Optimal Gleevec dosage was the primary focus of this study.

This webcast will help you gain more understanding of our study and review the data collected and the impact this research has on the wider GIST community.

This webcast presents critical data that will greatly affect GIST treatment!

To review the published data on the research study, please Click Here.

PLAY